Mechanisms for tolerance to methamphetamine effects

被引:28
作者
Gygi, MP [1 ]
Gygi, SP [1 ]
Johnson, M [1 ]
Wilkins, DG [1 ]
Gibb, JW [1 ]
Hanson, GR [1 ]
机构
[1] UNIV UTAH,DEPT PHARMACOL & TOXICOL,SALT LAKE CITY,UT 84112
关键词
methamphetamine; serotonin; tolerance; probenecid; tryptophan hydroxylase;
D O I
10.1016/S0028-3908(96)00045-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pretreatment with incremental increases in methamphetamine causes tolerance to serotonergic effects caused by challenging with multiple high doses of methamphetamine (11.5 mg/kg/dose). The brain concentration of methamphetamine following this challenge was reduced in tolerant rats, yet the plasma concentration was elevated. The tolerance was selective for methamphetamine and did not occur when cocaine was used in the pretreatment. The possibility that tolerance affects the distribution of methamphetamine in or out of the brain through an active transport system was examined by combining the transport-blocking drug, probenecid, with a low dose of methamphetamine. The presence of probenecid enhanced methamphetamine-induced serotonergic changes in the hippocampus. The brain concentration of methamphetamine increased in the presence of probenecid; however, a similar increase in the plasma methamphetamine concentration suggests that the effects of probenecid on methamphetamine distribution are not related to the redistribution of methamphetamine that occurs in tolerant animals. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:751 / 757
页数:7
相关论文
共 19 条
[1]  
ALBURGES ME, 1990, INVEST CLIN, V31, P165
[2]   BENEMID RHO-(DI-NORMAL-PROPYLSULFAMYL)-BENZOIC ACID - ITS RENAL AFFINITY AND ITS ELIMINATION [J].
BEYER, KH ;
RUSSO, HF ;
TILLSON, EK ;
MILLER, AK ;
VERWEY, WF ;
GASS, SR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1951, 166 (03) :625-640
[3]  
BHAKTHAVATSALAM P, 1987, J PHARMACOL EXP THER, V240, P196
[4]   TRANSPORT OF CIMETIDINE ACROSS THE BASOLATERAL MEMBRANE OF RABBIT KIDNEY PROXIMAL TUBULES - INTERACTION WITH ORGANIC-ANIONS [J].
BRANDLE, E ;
GREVEN, J .
PHARMACOLOGY, 1992, 45 (04) :231-240
[5]  
CALDWELL J, 1980, AMPHETAMINES RELATED, P131
[6]   CLINICAL PHARMACOKINETICS OF PROBENECID [J].
CUNNINGHAM, RF ;
ISRAILI, ZH ;
DAYTON, PG .
CLINICAL PHARMACOKINETICS, 1981, 6 (02) :135-151
[7]  
HOTCHKISS AJ, 1980, J PHARMACOL EXP THER, V214, P257
[8]  
Jaffe JH, 1990, PHARMACOL BASIS THER, P522
[9]  
JOHNSON M, 1992, J PHARMACOL EXP THER, V261, P447
[10]  
KATZ JL, 1993, J PHARMACOL EXP THER, V264, P183